# Danish Heart Foundation

Organization · id `cardio:org-danish-heart-foundation` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Danish+Heart+Foundation>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Danish Heart Foundation
- Sponsor class: OTHER

## Connected pages

- Sponsors: DANISH (`cardio:danish-trial`)
- Sponsors: Teledi@Log - Tele-rehabilitation of Heart Patients (`cardio:ct-nct01752192`)
- Sponsors: Future Patient - Telerehabilitation of Heart Failure Patients (`cardio:ct-nct03388918`)
- Sponsors: DANHEART (H-HeFT and Met-HeFT) (`cardio:ct-nct03514108`)
- Sponsors: The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis (`cardio:ct-nct03862859`)
- Sponsors: Cardiac Arrest in Residential Areas With Mobile First-responder Activation (`cardio:ct-nct04446585`)
- Sponsors: The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure (`cardio:ct-nct05042973`)
- Sponsors: The Cardiac Effects of Empagliflozin in Patients With High Risk of Heart Failure (`cardio:ct-nct05084235`)
- Sponsors: MEdical Treatment in Idiopathic Ventricular Fibrillation Patients (`cardio:ct-nct07405229`)

## Provenance

Content hash: bf06197a89546277e070082b47d9b3e1c4194e4c2ed4a65f5ac1a7bf28b26ac9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
